Black Cardiologists Contribute to Pivotal Study on Statins in African Americans

Simple item page
dc.contributor.authorNews, Rx
dc.date.accessioned2019-08-14T14:58:23Z
dc.date.available2019-08-14T14:58:23Z
dc.date.issued2004
dc.description.abstractNew clinical trial results were announced for the first-ever large-scale, prospective trial exclusively designed to compare the effects of statins in African-Americans, who are generally under represented in clinical trials. Data from the ARIES (African American Rosuvastatin Investigation of Efficacy and Safety) trial were presented at the American Heart Association's Annual Scientific Sessions in New Orleans. The Association of Black Cardiologists (ABC) partnered with AstraZeneca on the ARIES trial and played a pivotal role with patient and investigator recruitment, site support and patient and physician education.
dc.description.urihttps://www.questia.com/hbr-welcome
dc.identifierhttps://doi.org/10.13016/ntjt-r7v0
dc.identifier.citationNews, Rx (2004) Black Cardiologists Contribute to Pivotal Study on Statins in African Americans. Heart Disease Weekly. pp. 69-70.
dc.identifier.otherEprint ID 159
dc.identifier.urihttp://hdl.handle.net/1903/22349
dc.subjectCardiovascular Disease
dc.subjectHealth Risk Factors
dc.subjectstudies
dc.subjectstatins
dc.subjectAfrican Americans
dc.subjectcardiologists
dc.titleBlack Cardiologists Contribute to Pivotal Study on Statins in African Americans
dc.typeArticle

Files

Collections

Minority Health and Health Equity Archive